BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9864929)

  • 1. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
    Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
    Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
    Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA
    Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
    Tam CS; Wolf MM; Januszewicz EH; Prince HM; Westerman D; Seymour JF
    Cancer; 2004 May; 100(10):2181-9. PubMed ID: 15139062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
    Alliot C
    J Clin Oncol; 2003 Jul; 21(13):2626; author reply 2626-7. PubMed ID: 12829689
    [No Abstract]   [Full Text] [Related]  

  • 6. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
    Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
    Trojan A; Meier R; Licht A; Taverna C
    Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.
    Ai WZ; Kohrt HE; Timmerman J; Hwang J; Hsu FJ; Czerwinski DD; Taidi B; Levy R
    Am J Hematol; 2011 Jun; 86(6):515-8. PubMed ID: 21538469
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
    Czuczman MS; Koryzna A; Mohr A; Stewart C; Donohue K; Blumenson L; Bernstein ZP; McCarthy P; Alam A; Hernandez-Ilizaliturri F; Skipper M; Brown K; Chanan-Khan A; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-Lopez A; Bernstein SH
    J Clin Oncol; 2005 Feb; 23(4):694-704. PubMed ID: 15681517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
    Luminari S; Marcheselli L; Sacchi S; Pozzi S; Bari A; Ilariucci F; Stelitano C; Angrilli F; Lazzaro A; Baldini L
    Cancer; 2009 May; 115(9):1906-13. PubMed ID: 19248044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine.
    Tsutsumi Y; Kanamori H; Minami H; Musashi M; Fukushima A; Ehira N; Yamato H; Obara S; Ogura N; Tanaka J; Asaka M; Imamura M; Masauzi N
    Ann Hematol; 2005 Apr; 84(4):269-71. PubMed ID: 15592832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
    Touahri T; Pulik M; Fezoui H; Genet P; Lionnet F; Louvel D
    Int J Hematol; 2002 Jan; 75(1):111-2. PubMed ID: 11843284
    [No Abstract]   [Full Text] [Related]  

  • 15. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
    Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
    Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mitoxantrone in the treatment of indolent lymphomas.
    Hagemeister F; Cabanillas F; Coleman M; Gregory SA; Zinzani PL
    Oncologist; 2005 Feb; 10(2):150-9. PubMed ID: 15709217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
    Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
    Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
    Fabbri A; Lenoci M; Gozzetti A; Chitarrelli I; Olcese F; Raspadori D; Gobbi M; Lauria F
    Br J Haematol; 2007 Oct; 139(1):90-3. PubMed ID: 17854311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.